Cargando…

The ocular adverse effects of oral drugs

Some commonly prescribed drugs have ocular adverse effects. Many parts of the eye can be affected by oral drugs. Some ocular adverse effects may be reversed with medical or surgical intervention whereas other drugs may cause irreversible loss of vision The risk of visual loss can be reduced by a num...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Rawan, Mehta, Hemal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377292/
https://www.ncbi.nlm.nih.gov/pubmed/34421178
http://dx.doi.org/10.18773/austprescr.2021.028
_version_ 1783740629066448896
author Ahmad, Rawan
Mehta, Hemal
author_facet Ahmad, Rawan
Mehta, Hemal
author_sort Ahmad, Rawan
collection PubMed
description Some commonly prescribed drugs have ocular adverse effects. Many parts of the eye can be affected by oral drugs. Some ocular adverse effects may be reversed with medical or surgical intervention whereas other drugs may cause irreversible loss of vision The risk of visual loss can be reduced by a number of approaches, including monitoring for ocular toxicity, reducing the drug dose, or stopping the drug and looking for an alternative. This can be supported by good communication between the prescribing clinician and ophthalmologist Infrequent or delayed ocular adverse effects may not be identified in clinical trials of new drugs. Reporting adverse events is therefore important
format Online
Article
Text
id pubmed-8377292
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-83772922021-08-20 The ocular adverse effects of oral drugs Ahmad, Rawan Mehta, Hemal Aust Prescr Article Some commonly prescribed drugs have ocular adverse effects. Many parts of the eye can be affected by oral drugs. Some ocular adverse effects may be reversed with medical or surgical intervention whereas other drugs may cause irreversible loss of vision The risk of visual loss can be reduced by a number of approaches, including monitoring for ocular toxicity, reducing the drug dose, or stopping the drug and looking for an alternative. This can be supported by good communication between the prescribing clinician and ophthalmologist Infrequent or delayed ocular adverse effects may not be identified in clinical trials of new drugs. Reporting adverse events is therefore important NPS MedicineWise 2021-08-02 2021-08 /pmc/articles/PMC8377292/ /pubmed/34421178 http://dx.doi.org/10.18773/austprescr.2021.028 Text en 2020 NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle Article
Ahmad, Rawan
Mehta, Hemal
The ocular adverse effects of oral drugs
title The ocular adverse effects of oral drugs
title_full The ocular adverse effects of oral drugs
title_fullStr The ocular adverse effects of oral drugs
title_full_unstemmed The ocular adverse effects of oral drugs
title_short The ocular adverse effects of oral drugs
title_sort ocular adverse effects of oral drugs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377292/
https://www.ncbi.nlm.nih.gov/pubmed/34421178
http://dx.doi.org/10.18773/austprescr.2021.028
work_keys_str_mv AT ahmadrawan theocularadverseeffectsoforaldrugs
AT mehtahemal theocularadverseeffectsoforaldrugs
AT ahmadrawan ocularadverseeffectsoforaldrugs
AT mehtahemal ocularadverseeffectsoforaldrugs